We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener

Session

Breast
6006
Digital Poster
Clinical
Effects of socioeconomic factors on prognosis of breast cancer in patients younger than forty years.
Hilal Alkış , Turkey
PO-1083
Radiotherapy with simultaneous integrated boost for breast cancer: acute toxicity outcomes
Ivica Ratosa, Slovenia
PO-1084
Longitudinal assessment of immune infiltrate in breast cancer treated with neoadjuvant radiotherapy
Ruth Robinson, United Kingdom
PO-1085
Identification of highly expressed genes in high risk breast cancer using bioinformatic analysis
Shiva Ghasemi, Iran Islamic Republic of
PO-1086
Hypofractionated radiotherapy for breast cancer orbital lesion: a multicentric series of 35 patients
Isacco Desideri, Italy
PO-1087
Cardiac conduction system exposure during breast radiotherapy : evaluation of IMRT and protontherapy
Pierre Loap, France
PO-1088
Long-term follow-up of a single-center neuroendocrine breast cancer cohort
Pierre Loap, France
PO-1089
Tumor bed boost volume delineation and planning post-oncoplasty following multidisciplinary approach
tabassum wadasadawala, India
PO-1090
Positive axillary non-sentinel nodes predictors in breast cancer patients after neoadjuvant therapy
Eliana La Rocca, Italy
PO-1091
Gated Radiotherapy with deep inspiration breath-hold in left-sided breast cancer
Oliver Micke, Germany
PO-1092
Evaluating cardiac structures exposure in deep inspiration breathhold radiotherapy for breast cancer
Ghada Abdessatar, Tunisia
PO-1093
Deep Breath Inspiration Hold Radiotherapy: innovative organ preservation technique. Our experience.
Sara Falivene, Italy
PO-1094
Reducing overall treatment time, a pilot RCT of neo-adjuvant radiotherapy in early breast cancer
Vincent Vakaet, Belgium
PO-1095
Safety of concurrent TDM-1 and radiotherapy for patients with residual HER2-positive breast cancer
Carlotta Becherini, Italy
PO-1096
Preclinical evaluation for dose escalation in the preoperative SBRT of early breast cancer
Consiglia Piccolo, Italy
PO-1097
STANDARD RADIOTHERAPY FRACTIONATION TOXICITY VERSUS ULTRA-HYPOFRACTIONATION IN BREAST CANCER.
Cecilia Escuin , Spain
PO-1098
To plan and deliver adjuvant breast radiotherapy over 1 week: 1-week breast workflow implementation
Guillaume Louvel, France
PO-1099
Implementation of FAST-Forward during COVID19: Report of acute skin toxicity /resource implications
Killian Nugent, United Kingdom
PO-1100
Optimal strategy to detect sub-clinical cardiac alterations in left sided breast cancer
Nejla Fourati, Tunisia
PO-1101
INTRAOPERATIVE RADIOTHERAPY IN BREAST CANCER IN EARLY STAGES: LOCAL CONTROL AND TOXICITY.
Cecilia Escuin , Spain
PO-1102
Lung Cancer Mortality Among 316,336 Radiotherapy-Treated Early Stage Breast Cancer Cases
Semaw Abera, Germany
PO-1103
Once-weekly Hypofractionated Adjuvant Radiotherapy for Early Stage Breast Cancer
Ahmed Aly, Egypt
PO-1104
hypofractionated adjuvant radiotherapy in locally advanced breast cancer
Ahmed Aly, Egypt
PO-1105
External beam APBI in early breast cancer: randomised prospective single institution study.
Petr Burkon, Czech Republic
PO-1106
Inflammatory markers in breast cancer patients treated with radiotherapy: Machine Learning approach
Elisabet Rodríguez-Tomàs, Spain
PO-1107
Deep inspiration breath hold in prone photon or proton irradiation of breast and lymph nodes
Bruno Speleers, Belgium
PO-1108
Regional Nodal Irradiation for Node Positive Breast Cancer: Clinical Outcomes Reporting
Adam Peters, United Kingdom
PO-1109
Local control in hypofractionated RT after breast-conservative surgery among young Egyptian patients
Abeid Mohamed Athman Omar, Egypt
PO-1110
Is Calendula useful for radiation dermatitis in breast cancer? A single-centre clinical trial.
Paula Blasco Valls, Spain
PO-1111
Repeated courses of RT in breast cancer patients as salvage therapy for recurrent brain metastases
Alessia Di Donato, Italy
PO-1112
A dosimetric comparison of two external beam radiotherapy techniques: 3DCRT & Tomotherapy in APBI
Rajasree Rajan, India
PO-1113
“One minute” IORT for low-risk breast cancer: feasibility, reproducibility and early toxicity report
Marie-Eve Chand-Fouché, France
PO-1114
Extreme weekly locoregional hypofractionated radiation in elderly with non-metastatic breast cancer
Fadoua Rais, Canada
PO-1115
Evaluation of Nodal CTVs With Deformable Registration After Neoadjuvant Treatment in Breast Cancer
Menekşe Turna, Turkey
PO-1116
Incidental irradiation of the internal mammary in breast radiotherapy.
Laura Cardoso Rubio, Spain
PO-1117
Incidental dose to axilla in breast cancer patients undergoing post-operative radiotherapy
Khushboo Rastogi, India
PO-1118
Internal Mammary Irradiation in breast cancer. Do CTV-PTV safety margins matter?
Christopher Hofmann, Germany
PO-1119
skin toxicity of hypofractionated vs conventional irradiation after mastectomy for breast cancer
Meriem Bohli, Tunisia
PO-1120
Polymorphisms in DNA repair genes and radiotherapy late adverse events in breast cancer patients
Tanja Marinko, Slovenia
PO-1121
Early and intermediate treatment outcome after external beam accelerated partial breast irradiation
Anna Stenger-Weisser, Switzerland
PO-1122
Post mastectomy RT planning on institutional, RTOG & ESTRO contouring guidelines comparison
Biplab Sarkar, India
PO-1123
Is there a role for bolus in the modern era of breast cancer treatments? A retrospective analysis.
Cecília Félix Penido Mendes de Sousa, Brazil
PO-1124
Cardiac subvolume dosimetry in breast cancer patients receiving DIBH hypofractionated radiotherapy
Elisabet Gonzalez Del Portillo, Spain
PO-1125
Cardiotoxic effects of tangential breast irradiation?
Rebecca Buecker, Germany
PO-1126
Omission of axillary irradiation in breast cancer patients with ypN0 after neoadjuvant chemotherapy
Susana Sarandão , Portugal
PO-1127
Oesophagus exposure in breast cancer radiotherapy: systematic review of oesophageal doses 2010-2020
Fran Duane, Ireland
PO-1128
The acute and late toxicities of MRI-guided APBI delivered using a once-per-day regimen
Hye In Lee, Korea Republic of
PO-1129
Radiation Induced Skin Toxicity after HypoFractionated Radiotherapy: A prospective analysis
Maithili Sharma, India
PO-1130
Primary tumors observed in 1325 consecutive breast cancer patients treated with whole breast RT
Andrei Fodor, Italy
PO-1131
Incidental radiation to internal mammary nodes in breast cancer- comparison of conformal techniques
Ankita mehta, India
PO-1132
Deep inspiration breath hold: Dose comparison and anatomical factors analysis using 3D slicer
Chia-Chuan Kuo, Taiwan
PO-1133
MRI and PET response after preoperative radiochemotherapy in HER2+/triple negative breast cancer
Angel Montero, Spain
PO-1134
Ultra-hypofractionated whole breast radiotherapy with integrated boost for early breast cancer
Angel Montero, Spain
PO-1135
Radiotherapy for breast cancer in women with autoimmune rheumatologic diseases.
Lucrezia Gasparini, Italy
PO-1136
A prospective study on Quality of life in patients treated with radiotherapy for early breast cancer
Fiorella Cristina Di Guglielmo, Italy
PO-1137
Preoperative radiation therapy in breast cancer: preliminary results from ROCK trial (NCT03520894)
Vanessa Di Cataldo, Italy
PO-1138
Skin toxicity in 1325 breast cancer patients treated with hypofractionated RT without boost
Andrei Fodor, Italy
PO-1139
Reproducibility positioning in left side breast cancer patients with DIBH-SGRT-Catalyst system
DOLORES DE LA MATA MOYA, Mexico
PO-1140
Voluntary vs. mechanically induced DIBH for left breast cancer: a randomized trial
Loic Vander Veken, Belgium
PO-1141
Hypofractionated whole breast radiotherapy in large breast size: is it really a solved issue?
Riccardo Ray Colciago, Italy
PO-1142
One-week ultrahypofractionated RT for whole breast and simultaneous integrated boost in DCIS
Raquel Ciervide, Spain
PO-1143
Analysis of geometric and dosimetric effects of bra application during breast radiotherapy planning
Jinhyun Choi, Korea Republic of
PO-1144
Evaluation of deep learning-based auto-segmentation of OARs for breast cancer radiotherapy
Hwa Kyung Byun, Korea Republic of
PO-1145
Perioperative HDR brachytherapy for breast cancer, technique implementation in a single institution
Miren Gaztañaga, Spain
PO-1146
Whole breast Radiotherapy in cT1-2 cN0 with pN+ sentinel nodes: preliminary results of LISEN trial
Marzia Borgia, Italy
PO-1147